Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
10.34
+0.06 (0.58%)
At close: Dec 5, 2025
SHE:301301 Market Cap
SHE:301301 has a market cap or net worth of 23.06 billion as of December 5, 2025. Its market cap has decreased by -33.42% in one year.
Market Cap
23.06B
Enterprise Value
23.56B
Revenue
4.74B
Ranking
n/a
PE Ratio
24.75
Stock Price
10.34
Market Cap Chart
Since December 27, 2022, SHE:301301's market cap has increased from 22.34B to 23.06B, an increase of 3.22%. That is a compound annual growth rate of 1.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 23.06B | -12.70% |
| Dec 31, 2024 | 26.41B | 41.47% |
| Dec 29, 2023 | 18.67B | -6.15% |
| Dec 30, 2022 | 19.89B | -10.95% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 407.03B |
| WuXi AppTec | 269.55B |
| Shenzhen Mindray Bio-Medical Electronics | 244.77B |
| Sichuan Biokin Pharmaceutical | 150.71B |
| Shanghai United Imaging Healthcare | 105.68B |
| Aier Eye Hospital Group | 105.04B |
| Zhangzhou Pientzehuang Pharmaceutical., | 101.93B |
| Yunnan Baiyao Group Co.,Ltd | 99.79B |